Literature DB >> 29885334

Compartmentalized cyclic nucleotides have opposing effects on regulation of hypertrophic phospholipase Cε signaling in cardiac myocytes.

Craig A Nash1, Loren M Brown1, Sundeep Malik2, Xiaodong Cheng3, Alan V Smrcka4.   

Abstract

In cardiac myocytes activation of an exchange factor activated by cAMP (Epac) leads to activation of phospholipase Cε (PLCε)-dependent hydrolysis of phosphatidylinositol 4-phosphate (PI4P) in the Golgi apparatus a process critical for development of cardiac hypertrophy. Here we show that β-adrenergic receptor (βAR) stimulation does not stimulate this pathway in the presence of the broad spectrum phosphodiesterase (PDE) inhibitor IBMX, but selective PDE3 inhibition revealed βAR-dependent PI4P depletion. On the other hand, selective inhibition of PDE2 or PDE9A blocked endothelin-1 (ET-1) and cAMP-dependent PI4P hydrolysis by PLCε. Direct activation of protein kinase A (PKA), protein kinase G (PKG), or the atrial natriuretic factor (ANF) receptor abolished PI4P hydrolysis in response to multiple upstream stimuli. These results reveal distinct pools of cyclic nucleotides that either inhibit PLCε at the Golgi through PKA/PKG, or activate PLCε at the Golgi through Epac. These data together reveal a new mechanism by which ANF and selective PDE inhibitors can protect against cardiac hypertrophy.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  A kinase anchoring protein; Cardiac hypertrophy; Cyclic AMP; Epac; Golgi apparatus; Phosphatidylinositol 4-phosphate; Phosphodiesterase; Phospholipase C

Mesh:

Substances:

Year:  2018        PMID: 29885334      PMCID: PMC6373484          DOI: 10.1016/j.yjmcc.2018.06.002

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  39 in total

1.  Phospholipase C(epsilon): a novel Ras effector.

Authors:  G G Kelley; S E Reks; J M Ondrako; A V Smrcka
Journal:  EMBO J       Date:  2001-02-15       Impact factor: 11.598

Review 2.  Phosphodiesterases and subcellular compartmentalized cAMP signaling in the cardiovascular system.

Authors:  Alessandra Stangherlin; Manuela Zaccolo
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-10-28       Impact factor: 4.733

Review 3.  Role of phospholipase Cε in physiological phosphoinositide signaling networks.

Authors:  Alan V Smrcka; Joan Heller Brown; George G Holz
Journal:  Cell Signal       Date:  2012-01-20       Impact factor: 4.315

4.  Expression of cyclic GMP-inhibited phosphodiesterases 3A and 3B (PDE3A and PDE3B) in rat tissues: differential subcellular localization and regulated expression by cyclic AMP.

Authors:  H Liu; D H Maurice
Journal:  Br J Pharmacol       Date:  1998-12       Impact factor: 8.739

5.  Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy.

Authors:  Eiki Takimoto; Hunter C Champion; Manxiang Li; Diego Belardi; Shuxun Ren; E Rene Rodriguez; Djahida Bedja; Kathleen L Gabrielson; Yibin Wang; David A Kass
Journal:  Nat Med       Date:  2005-01-23       Impact factor: 53.440

6.  Phospholipase Cbeta1b associates with a Shank3 complex at the cardiac sarcolemma.

Authors:  David R Grubb; Peter Iliades; Nicola Cooley; Yen Lin Yu; Jieting Luo; Theresa M Filtz; Elizabeth A Woodcock
Journal:  FASEB J       Date:  2010-12-09       Impact factor: 5.191

7.  Enhanced Galphaq signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure.

Authors:  J W Adams; Y Sakata; M G Davis; V P Sah; Y Wang; S B Liggett; K R Chien; J H Brown; G W Dorn
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

8.  Hormonal regulation of phospholipase Cepsilon through distinct and overlapping pathways involving G12 and Ras family G-proteins.

Authors:  Grant G Kelley; Sarah E Reks; Alan V Smrcka
Journal:  Biochem J       Date:  2004-02-15       Impact factor: 3.857

Review 9.  cAMP and cGMP signaling cross-talk: role of phosphodiesterases and implications for cardiac pathophysiology.

Authors:  Manuela Zaccolo; Matthew A Movsesian
Journal:  Circ Res       Date:  2007-06-08       Impact factor: 17.367

10.  G protein βγ subunits regulate cardiomyocyte hypertrophy through a perinuclear Golgi phosphatidylinositol 4-phosphate hydrolysis pathway.

Authors:  S Malik; R G deRubio; M Trembley; R Irannejad; P B Wedegaertner; A V Smrcka
Journal:  Mol Biol Cell       Date:  2015-01-21       Impact factor: 4.138

View more
  11 in total

1.  Intramolecular electrostatic interactions contribute to phospholipase Cβ3 autoinhibition.

Authors:  Candi M Esquina; Elisabeth E Garland-Kuntz; Daniel Goldfarb; Emily K McDonald; Brianna N Hudson; Angeline M Lyon
Journal:  Cell Signal       Date:  2019-06-26       Impact factor: 4.315

2.  Subcellular β-Adrenergic Receptor Signaling in Cardiac Physiology and Disease.

Authors:  Wenhui Wei; Alan V Smrcka
Journal:  J Cardiovasc Pharmacol       Date:  2022-09-01       Impact factor: 3.271

Review 3.  Cyclic nucleotide phosphodiesterases as therapeutic targets in cardiac hypertrophy and heart failure.

Authors:  Rima Kamel; Jérôme Leroy; Grégoire Vandecasteele; Rodolphe Fischmeister
Journal:  Nat Rev Cardiol       Date:  2022-09-01       Impact factor: 49.421

Review 4.  Calcineurin-AKAP interactions: therapeutic targeting of a pleiotropic enzyme with a little help from its friends.

Authors:  Moriah Gildart; Michael S Kapiloff; Kimberly L Dodge-Kafka
Journal:  J Physiol       Date:  2018-12-26       Impact factor: 5.182

Review 5.  Structure and regulation of phospholipase Cβ and ε at the membrane.

Authors:  Kaushik Muralidharan; Michelle M Van Camp; Angeline M Lyon
Journal:  Chem Phys Lipids       Date:  2021-01-07       Impact factor: 3.329

6.  Golgi localized β1-adrenergic receptors stimulate Golgi PI4P hydrolysis by PLCε to regulate cardiac hypertrophy.

Authors:  Craig A Nash; Wenhui Wei; Roshanak Irannejad; Alan V Smrcka
Journal:  Elife       Date:  2019-08-21       Impact factor: 8.140

7.  Functional and structural characterization of allosteric activation of phospholipase Cε by Rap1A.

Authors:  Monita Sieng; Arielle F Selvia; Elisabeth E Garland-Kuntz; Jesse B Hopkins; Isaac J Fisher; Andrea T Marti; Angeline M Lyon
Journal:  J Biol Chem       Date:  2020-09-18       Impact factor: 5.157

Review 8.  GRKs and Epac1 Interaction in Cardiac Remodeling and Heart Failure.

Authors:  Marion Laudette; Karina Formoso; Frank Lezoualc'h
Journal:  Cells       Date:  2021-01-14       Impact factor: 6.600

Review 9.  The Epac1 Protein: Pharmacological Modulators, Cardiac Signalosome and Pathophysiology.

Authors:  Marion Bouvet; Jean-Paul Blondeau; Frank Lezoualc'h
Journal:  Cells       Date:  2019-11-29       Impact factor: 6.600

Review 10.  Therapeutic Implications for PDE2 and cGMP/cAMP Mediated Crosstalk in Cardiovascular Diseases.

Authors:  Mirna S Sadek; Eleder Cachorro; Ali El-Armouche; Susanne Kämmerer
Journal:  Int J Mol Sci       Date:  2020-10-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.